受强制性开放获取政策约束的文章 - Eric Bartee了解详情
可在其他位置公开访问的文章：42 篇
Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes
J Thibodeau, MC Bourgeois‐Daigneault, G Huppé, J Tremblay, A Aumont, ...
European journal of immunology 38 (5), 1225-1230, 2008
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research …
Cytokine determinants of viral tropism
G McFadden, MR Mohamed, MM Rahman, E Bartee
Nature Reviews Immunology 9 (9), 645-655, 2009
强制性开放获取政策： US National Institutes of Health
Tumor-localized secretion of soluble PD1 enhances oncolytic virotherapy
MY Bartee, KM Dunlap, E Bartee
Cancer research 77 (11), 2952-2963, 2017
强制性开放获取政策： US National Institutes of Health
RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages
F Wang, X Gao, JW Barrett, Q Shao, E Bartee, MR Mohamed, M Rahman, ...
PLoS pathogens 4 (7), e1000099, 2008
强制性开放获取政策： Howard Hughes Medical Institute, Canadian Institutes of Health Research
The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts
E Bartee, MR Mohamed, MC Lopez, HV Baker, G McFadden
Journal of virology 83 (2), 498-511, 2009
强制性开放获取政策： Howard Hughes Medical Institute
Fueling cancer immunotherapy with common gamma chain cytokines
CJ Dwyer, HM Knochelmann, AS Smith, MM Wyatt, GO Rangel Rivera, ...
Frontiers in immunology 10, 263, 2019
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs
Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes
E Bartee, CA Eyster, K Viswanathan, M Mansouri, JG Donaldson, K Früh
PloS one 5 (12), e15132, 2010
强制性开放获取政策： US National Institutes of Health
Cytokine synergy: an underappreciated contributor to innate anti-viral immunity
E Bartee, G McFadden
Cytokine 63 (3), 237-240, 2013
强制性开放获取政策： US National Institutes of Health
Tumor necrosis factor and interferon: cytokines in harmony
E Bartee, MR Mohamed, G McFadden
Current Opinion in Microbiology 11 (4), 378-383, 2008
强制性开放获取政策： Howard Hughes Medical Institute
Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus
E Bartee, WM Chan, JS Moreb, CR Cogle, G McFadden
Biology of blood and marrow transplantation 18 (10), 1540-1551, 2012
强制性开放获取政策： US National Institutes of Health
Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-β
E Bartee, G McFadden
Cytokine 47 (3), 199-205, 2009
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
Oncolytic virotherapy for hematological malignancies
S Bais, E Bartee, MM Rahman, G McFadden, CR Cogle
Advances in virology 2012 (1), 186512, 2012
强制性开放获取政策： US National Institutes of Health
Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells
NY Villa, E Bartee, MR Mohamed, MM Rahman, JW Barrett, G McFadden
Virology 401 (2), 266-279, 2010
强制性开放获取政策： US National Institutes of Health
Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice
E Bartee, MY Bartee, B Bogen, XZ Yu
Molecular Therapy-Oncolytics 3, 2016
强制性开放获取政策： US National Institutes of Health
Myxoma and vaccinia viruses bind differentially to human leukocytes
WM Chan, EC Bartee, JS Moreb, K Dower, JH Connor, G McFadden
Journal of virology 87 (8), 4445-4460, 2013
强制性开放获取政策： US National Institutes of Health
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro
GJ Madlambayan, E Bartee, M Kim, MM Rahman, A Meacham, EW Scott, ...
Leukemia research 36 (5), 619-624, 2012
强制性开放获取政策： US National Institutes of Health
Myxoma virus induces ligand independent extrinsic apoptosis in human myeloma cells
MY Bartee, KM Dunlap, E Bartee
Clinical Lymphoma Myeloma and Leukemia 16 (4), 203-212, 2016
强制性开放获取政策： US National Institutes of Health
The use of oncolytic virotherapy in the neoadjuvant setting
RJ Thomas, E Bartee
Journal for immunotherapy of cancer 10 (4), 2022
强制性开放获取政策： US National Institutes of Health
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
C Burton, A Das, D McDonald, WA Vandergrift III, SJ Patel, D Cachia, ...
Oncolytic virotherapy, 107-116, 2018
强制性开放获取政策： US National Institutes of Health
Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor–resistant multiple myeloma
KM Dunlap, MY Bartee, E Bartee
Oncolytic virotherapy, 1-11, 2015
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定